A Multicenter, Open-Label, Randomized, Controlled Study to Compare the Effects on Bone Mineral Density of DR-105 and a 28-Day Cycle Oral Contraceptive Regimen in Healthy, Postmenarchal, Adolescent Females.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2014
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol
- Indications Pregnancy
- Focus Pharmacodynamics
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Aug 2012 Planned end date changed from 1 Aug 2012 to 1 Oct 2012 as reported by ClinicalTrials.gov.
- 22 Aug 2011 Planned end date changed from 1 Jun 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.